[How promising is decontamination treatment of MRSA carriers?].
Panknin
Hardy-Thorsten
HT
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy*; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D003666:Decontamination / Q000379:methods*; D006801:Humans; D016106:Methicillin Resistance; D016712:Mupirocin / Q000627:therapeutic use; D012915:Soaps / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000382:microbiology / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D012915:Soaps; D016712:Mupirocin